APA (7th ed.) Citation

Montrucchio, G., Sales, G., Rumbolo, F., Palmesino, F., Fanelli, V., Urbino, R., . . . Brazzi, L. (2021). Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Montrucchio, Giorgia, Gabriele Sales, Francesca Rumbolo, Filippo Palmesino, Vito Fanelli, Rosario Urbino, Claudia Filippini, Giulio Mengozzi, and Luca Brazzi. Effectiveness of Mid-regional Pro-adrenomedullin (MR-proADM) as Prognostic Marker in COVID-19 Critically Ill Patients: An Observational Prospective Study. Public Library of Science (PLoS), 2021.

MLA (9th ed.) Citation

Montrucchio, Giorgia, et al. Effectiveness of Mid-regional Pro-adrenomedullin (MR-proADM) as Prognostic Marker in COVID-19 Critically Ill Patients: An Observational Prospective Study. Public Library of Science (PLoS), 2021.